AD: Promising Long-Term Safety Profile for Dupilumab in Real-World Data
Thrasyvoulos Tzellos presents in this MEDtalk the results from a multinational prospective long-term study that assessed both efficacy and safety for treatment with dupilumab in real-world practice. According to Thrasyvoulos Tzellos, the study’s results are very promising in terms of safety.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
